Approvals/TGA/TRIPACEL pertussis vaccine - acellular combined with diphtheria and tetanus toxoids (adsorbed)

Approved

STANDARD

TRIPACEL pertussis vaccine - acellular combined with diphtheria and tetanus toxoids (adsorbed)

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b7dc596f1b9715cd
Product Name: TRIPACEL pertussis vaccine - acellular combined with diphtheria and tetanus toxoids (adsorbed)
Artg Id: 63120
Artg Name: TRIPACEL pertussis vaccine - acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection vial
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 1998-04-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4454d4c76520a4e8b3c18b59f589b5d1.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/caf73923e2f97e3f0dfb997c5216b306.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

b7dc596f1b9715cd

Type

Standard